Inhibitors of Hsp90 (e.g. 17-DMAG) induce ZAP-70 degradation and apoptosis of CLL cells and are tested in ongoing clinical trials in CLL. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.